Skip to content
Trial Eligibility
Menu

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

NCT02560805

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to find out why patients with post-traumatic stress disorder (PTSD) have an increased risk for heart disease and high blood pressure later in life. A second purpose is to find out what causes PTSD patients to have high adrenaline levels during stress. This study will also test if a medicine called losartan improves high adrenaline levels in patients with PTSD and if a certain gene that has to do with high blood pressure might be associated with high adrenaline levels.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Stress Disorders, Post-Traumatic

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Emory University
Last updated on ClinicalTrials.gov
May 18, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Georgia · 1

  • Atlanta VA Medical Center · Decatur, GA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.